共 195 条
[1]
Guo XF(2018)Fatty acid and non-alcoholic fatty liver disease: meta-analyses of case-control and randomized controlled trials Clin Nutr 37 113-122
[2]
Yang B(2016)Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes Hepatology 64 73-84
[3]
Tang J(2007)Non-alcoholic fatty liver disease and increased risk of cardiovascular disease Atherosclerosis 191 235-240
[4]
Li D(2019)The global epidemiology of NAFLD and NASH in patients with type 2 diabetes: a systematic review and meta-analysis J Hepatol 71 793-801
[5]
Younossi ZM(2015)Nonalcoholic fatty liver disease: a systematic review JAMA 313 2263-2273
[6]
Koenig AB(2015)Weight loss via lifestyle modification significantly reduces features of nonalcoholic steatohepatitis Gastroenterology 363 1185-1727
[7]
Abdelatif D(2010)Pioglitazone, vitamin E, or placebo for nonalcoholic steatohepatitis N Engl J Med 21 1718-7399
[8]
Fazel Y(2015)Vitamin D: a new player in non-alcoholic fatty liver disease? World J Gastroenterol 11 7389-3429
[9]
Henry L(2020)Vitamin D and non-alcoholic fatty liver disease: a meta-analysis of randomized controlled trials Food Func 57 3421-3393
[10]
Wymer M(2017)Anti-inflammatory effects of omega 3 and omega 6 polyunsaturated fatty acids in cardiovascular disease and metabolic syndrome Crit Rev Food Sci Nutr 59 3380-4061